This sensitization was also reported as a bortezomib-induced “BRCAness” that sensitizes MM cell lines and primary CD138+ cells to poly ADP ribose polymerase (PARP) inhibitors and confirmed in MM xenografts in SCID mice [33]. This evidence concerns the gene PARP1 and Miyoshi myopathy.